Arca Biopharma | ABIO - Koszty Operacyjne





Koszty Operacyjne Zmiana Data
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Amgen USD 4.78B 1.12B 2026-03
Arca Biopharma USD 34.43M 326K 2025-12
Biogen USD 1.96B 69.6M 2026-03
Brainstorm Cell Therapeutics USD 2.24M 197K 2025-12
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cipla INR 60.98B 1.06B 2025-12
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.29M 1.51M 2025-12
CSL USD 5.7B 2.82B 2025-12
Cytokinetics USD 196.12M 27.43M 2025-12
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Grifols EUR 1.99B 217.4M 2025-12
Laboratory Of America USD 3.13B 6.3M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
Otsuka Holdings JPY 512.13B 70.77B 2026-03
Pfizer USD 90.1B 77.19B 2026-03
United Therapeutics USD 804.8M 5.79B 2025-12